[Treatment of acute myeloblastic leukemia by the combination of daunorubicin (or rubidazone) and cytosine arabinoside (apropos of 76 cases)].
D000208:Acute Disease; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged
D000970:Antineoplastic Agents; D003561:Cytarabine; C002205:zorubicin; D003630:Daunorubicin
Le traitement de la leucémie aiguë myéloblastique par l'association daunorubicine (ou rubidazone) cytosine-arabinoside. (á propos de 76 observations).